1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Advanced Bladder Cancer: new trials by email Literature Review of Advanced Bladder Cancer trials Research Report on Advanced Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer enfortumab vedotin and pembrolizumab (EV/P) - Advanced Bladder Cancer | Phase 3 | Not yet recruiting | Guliz Ozgun | 224 | 2026-11-01 | 2026-10-01 |
enfortumab vedotin (1) · pembrolizumab (1)
Guliz Ozgun (1)
Canada (1)